S. Monaco

Latest

• Increased NK Cell Count in Multiple Sclerosis Patients Treated With Dimethyl Fumarate: A 2-Year Longitudinal Study
• Inflammatory intrathecal profiles and cortical damage in multiple sclerosis
• The cortical damage, early relapses, and onset of the progressive phase in multiple sclerosis
• The effect of fingolimod on focal and diffuse grey matter damage in active MS patients
• Cognitive impairment predicts disability progression and cortical thinning in MS: An 8-year study
• Regional distribution and evolution of gray matter damage in different populations of multiple sclerosis patients